Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Chubb
Fish and Richardson
McKinsey
QuintilesIMS
Farmers Insurance
Boehringer Ingelheim
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

CHLORZOXAZONE Drug Profile

« Back to Dashboard

When do Chlorzoxazone patents expire, and when can generic versions of Chlorzoxazone launch?

Chlorzoxazone is a drug marketed by Actavis Elizabeth, Aurolife Pharma Llc, Barr, Mikart, Mikart Inc, Ohm Labs, Par Pharm, Pioneer Pharms, Sun Pharm Industries, and Watson Labs. and is included in nineteen NDAs.

The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Drug patent expirations by year for CHLORZOXAZONE
Pharmacology for CHLORZOXAZONE
Medical Subject Heading (MeSH) Categories for CHLORZOXAZONE
Synonyms for CHLORZOXAZONE
2-BENZOXAZOLINONE, 5-CHLORO-
2-Hydroxy-5-chlorobenzoxazole
2(3H)-Benzoxazolone, 5-chloro-
32850-84-3
5-chloranyl-3H-1,3-benzoxazol-2-one
5-Chlorbenzoxazolin-2-on
5-chloro-1,3-benzoxazol-2-ol
5-Chloro-1,3-benzoxazol-2(3H)-one
5-Chloro-1,3-benzoxazol-2(3H)-one #
5-chloro-1,3-benzoxazole-2(3H)-one
5-Chloro-2-benzoxazolinone
5-Chloro-2-benzoxazolol
5-Chloro-2-benzoxazolone
5-Chloro-2-hydroxybenzoxazole
5-chloro-2,3-dihydro-1,3-benzoxazol-2-one
5-Chloro-2,3-dihydro-2-oxo-1,3-benzoxazole
5-Chloro-2(3H)-benzoxazolone
5-Chloro-2(3H)-benzoxazolone; 5-Chloro-2-hydroxybenzoxazole
5-chloro-3-hydrobenzoxazol-2-one
5-Chloro-3(H)-2-benzoxazolone
5-chloro-3H-1,3-benzoxazol-2-one
5-chloro-3H-benzooxazol-2-one
5-Chloro-3H-benzoxazol-2-one
5-Chloro-benzooxazol-2-ol
5-chloro-benzoxazolin-2-one
5-chlorobenzo[d]oxazol-2-ol
5-Chlorobenzo[d]oxazol-2(3H)-one
5-Chlorobenzoksazolinon-2
5-Chlorobenzoksazolinon-2 [Polish]
5-Chlorobenzoksazolon-2
5-Chlorobenzoksazolon-2 [Polish]
5-Chlorobenzoxazol-2-one
5-Chlorobenzoxazolidone
5-chlorobenzoxazolin-2-one
5-Chlorobenzoxazolinone
5-Chlorobenzoxazolone
95-25-0
A845253
AB00051947
AB00051947_05
AB00051947_06
AB0011060
AB1004047
AC 303-630
AC-12192
AC1L1ECE
AC1Q3KM0
AC1Q3KM1
ACT08248
AI3-63119
AK158920
AKOS000404381
ALBB-012641
AN-24309
BBL003952
BDBM50290811
Biomioran
BP-11613
BPBio1_000029
BRD-K98174813-001-05-7
BSPBio_000025
BSPBio_002019
C 4397
C07931
C7H4ClNO2
CAS-95-25-0
CCG-40323
CHEBI:3655
CHEMBL1371
Chloroxazone
Chlorsoxazone
Chlorzoxane
Chlorzoxazon
chlorzoxazona
Chlorzoxazone (JAN/USP/INN)
Chlorzoxazone [INN:BAN:JAN]
Chlorzoxazone [USP:INN:BAN:JAN]
Chlorzoxazone 1.0 mg/ml in Acetonitrile
Chlorzoxazone-2-13C-3-15N-hydroxyl-18O
Chlorzoxazone, United States Pharmacopeia (USP) Reference Standard
Chlorzoxazonum
Chlorzoxazonum [INN-Latin]
Citrex (acaricide)
Clorzoxazona
Clorzoxazona [INN-Spanish]
Clorzoxazone
CLW
component of Parafon Forte
component of Parafon Forte (Salt/Mix)
CPD000058269
CS-5155
CTK6H1680
D00771
D08ZEB
DB00356
DivK1c_000895
DSSTox_CID_2813
DSSTox_GSID_22813
DSSTox_RID_76739
DTXSID9022813
EINECS 202-403-9
EN300-31026
Escoflex
EU-0100253
EZE-DS
FT-0620220
GTPL2322
H0DE420U8G
HE009247
HE281167
HE419195
HE419196
HE419197
HG-0202
HMS1568B07
HMS1920O07
HMS2091E14
HMS2095B07
HMS2235I19
HMS3259I15
HMS3260D08
HMS3373P17
HMS3652K22
HMS502M17
HY-B1462
I14-4579
IDI1_000895
InChI=1/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10
KB-88347
KBio1_000895
KBio2_000628
KBio2_003196
KBio2_005764
KBio3_001239
KBioGR_000814
KBioSS_000628
Klorzoxazon
KM3336
KS-00000VVL
Lopac-C-4397
Lopac0_000253
Lorzone
LP00253
LS-42267
McNeil Brand of Chlorzoxazone
MCULE-3638156868
MFCD00005717
Mioran
Miotran
MLS000069380
MolPort-001-759-947
MolPort-006-110-468
Muscol (TN)
Myoflexin
Myoflexine
Mystox MP
NC00499
NCGC00015238-01
NCGC00015238-02
NCGC00015238-03
NCGC00015238-04
NCGC00015238-05
NCGC00015238-06
NCGC00015238-07
NCGC00015238-08
NCGC00015238-09
NCGC00015238-10
NCGC00015238-13
NCGC00093714-01
NCGC00093714-02
NCGC00093714-03
NCGC00093714-04
NCGC00260938-01
Neoflex
NINDS_000895
NSC 26189
NSC-26189
NSC-756693
NSC26189
NSC756693
Nyoflex
Opera_ID_1659
Ortho Brand of Chlorzoxazone
Paraflex
Paraflex (TN)
Parafon
Parafon Forte
Parafon Forte (TN)
Parafon Forte DSC
Pathorysin
Phantom
Pharmakon1600-01500188
Prestwick_62
Prestwick0_000163
Prestwick1_000163
Prestwick2_000163
Prestwick3_000163
PubChem8642
Relaxazone
Remofleks
Remular
Remular-S
s4155
SAM002554888
SBB003864
SBI-0050241.P004
SC-07433
SCHEMBL35177
Secure 360SC Insecticide-Miticide
SMR000058269
Solaxin
SPBio_001077
SPBio_001946
Spectrum_000148
SPECTRUM1500188
Spectrum2_001149
Spectrum3_000350
Spectrum4_000287
Spectrum5_000745
SR-01000075207
SR-01000075207-1
ST2406217
ST45024437
Stealth
STK071582
STR00805
Strifon
Strifon Forte Dsc
Tox21_110105
Tox21_110105_1
Tox21_500253
TZFWDZFKRBELIQ-UHFFFAOYSA-N
UNII-H0DE420U8G
Usaf ma-10
W-100168
WLN: T56 BMVOJ HG
Z57183224
ZINC84843283

US Patents and Regulatory Information for CHLORZOXAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth CHLORZOXAZONE chlorzoxazone TABLET;ORAL 088928-001 May 8, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CHLORZOXAZONE chlorzoxazone TABLET;ORAL 081019-001 Jul 29, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mikart CHLORZOXAZONE chlorzoxazone TABLET;ORAL 040861-002 Jun 1, 2010 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurolife Pharma Llc CHLORZOXAZONE chlorzoxazone TABLET;ORAL 089853-001 May 4, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Fuji
Chinese Patent Office
Healthtrust
AstraZeneca
Cerilliant
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.